Neoantigenics Company
.jpg)
Neoantigenics is a liability company that focuses on developing oncology theranostics.
Total Funding:
$2 536 862
Headquarters:
Charlottesville, Virginia, United States
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Industry:
Women Cancer Treatment